This announcement is a separate document:
大湖水殖股份有限公司拟转让股权涉及湖南德海医药贸易有限公司股东全部权益价值资产评估报告（北京亚超评报字（2023）第A158号）
Dahu Aquaculture Co., Ltd. plans to transfer shares involving the full equity value and asset evaluation report of the shareholders of Hunan Dehai Pharmaceutical Trading Co., Ltd. (Beijing Asia Super League Review Report (2023) No. A158)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.